NVLN
Novelion Therapeutics Inc. Common Shares
NVLN
NVLN
Delisted
NVLN was delisted on the 8th of October, 2019.
49 hedge funds and large institutions have $39.7M invested in Novelion Therapeutics Inc. Common Shares in 2018 Q3 according to their latest regulatory filings, with 4 funds opening new positions, 6 increasing their positions, 14 reducing their positions, and 8 closing their positions.
New
Increased
Maintained
Reduced
Closed
more call options, than puts
Call options by funds: $ | Put options by funds: $
less funds holding
Funds holding: →
less capital invested
Capital invested by funds: $ → $
less funds holding in top 10
Funds holding in top 10: →
50% less first-time investments, than exits
New positions opened: 4 | Existing positions closed: 8
57% less repeat investments, than reductions
Existing positions increased: 6 | Existing positions reduced: 14
Holders
49
Holding in Top 10
2
Calls
$288K
Puts
$169K
Top Buyers
| 1 | +$738K | |
| 2 | +$189K | |
| 3 | +$51.1K | |
| 4 |
AA
Ancora Advisors
Cleveland,
Ohio
|
+$15K |
| 5 |
UBS Group
Zurich,
Switzerland
|
+$13.2K |
Top Sellers
| 1 | -$1.93M | |
| 2 | -$894K | |
| 3 | -$492K | |
| 4 |
Millennium Management
New York
|
-$293K |
| 5 |
SCM
Stonepine Capital Management
Bend,
Oregon
|
-$190K |